Katayama S - Search Results

1

Circulating p53 antibody in patients with colorectal cancer: relation to clinicopathologic features and survival.

Shiota G, Ishida M, Noguchi N, Oyama K, Takano Y, Okubo M, Katayama S, Tomie Y, Harada K, Hori K, Ashida K, Kishimoto Y, Hosoda A, Suou T, Kanbe T, Tanaka K, Nosaka K, Tanida O, Kojo H, Miura K, Ito H, Kaibara N, Kawasaki H. Shiota G, et al. Among authors: katayama s. Dig Dis Sci. 2000 Jan;45(1):122-8. doi: 10.1023/a:1005473729976. Dig Dis Sci. 2000. PMID: 10695624

2

Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.

Shiota G, Kishimoto Y, Suyama A, Okubo M, Katayama S, Harada K, Ishida M, Hori K, Suou T, Kawasaki H. Shiota G, et al. Among authors: katayama s. J Hepatol. 1997 Oct;27(4):661-8. doi: 10.1016/s0168-8278(97)80083-9. J Hepatol. 1997. PMID: 9365042 Clinical Trial.

3

Clinical significance of serum P53 antibody in patients with gastric cancer.

Shiota G, Ishida M, Noguchi N, Takano Y, Oyama K, Okubo M, Katayama S, Harada K, Hori K, Ashida K, Kishimoto Y, Hosoda A, Suou T, Ito H, Kawasaki H. Shiota G, et al. Among authors: katayama s. Res Commun Mol Pathol Pharmacol. 1998 Jan;99(1):41-51. Res Commun Mol Pathol Pharmacol. 1998. PMID: 9523354 Clinical Trial.

4

[Diagnostic significance of telomerase activity and telomere length in endoscopic sample of colorectal cancer].

Katayama S, Shiota G, Kawasaki H. Katayama S, et al. Nihon Rinsho. 1998 May;56(5):1204-8. Nihon Rinsho. 1998. PMID: 9613123 Japanese.

5

Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice.

Shiota G, Harada K, Ishida M, Tomie Y, Okubo M, Katayama S, Ito H, Kawasaki H. Shiota G, et al. Among authors: katayama s. Carcinogenesis. 1999 Jan;20(1):59-63. doi: 10.1093/carcin/20.1.59. Carcinogenesis. 1999. PMID: 9934850

6

Clinical usefulness of telomerase activity and telomere length in the preoperative diagnosis of gastric and colorectal cancer.

Katayama S, Shiota G, Oshimura M, Kawasaki H. Katayama S, et al. J Cancer Res Clin Oncol. 1999 Jul;125(7):405-10. doi: 10.1007/s004320050294. J Cancer Res Clin Oncol. 1999. PMID: 10394961

7

Abnormal prothrombin: evaluation as a tumour marker and localization in tissues of patients with hepatocellular carcinoma.

Koda T, Yamazaki S, Tamura I, Nakaba H, Takao T, Katayama S, Kurimura O. Koda T, et al. Among authors: katayama s. J Gastroenterol Hepatol. 1993 May-Jun;8(3):212-6. doi: 10.1111/j.1440-1746.1993.tb01188.x. J Gastroenterol Hepatol. 1993. PMID: 7686054

8

Significance of the molar ratio of branched-chain amino acids to tyrosine before hepatectomy.

Kohashi T, Itamoto T, Katayama K, Katayama S, Hino H, Nakahara H, Tashiro H, Asahara T. Kohashi T, et al. Among authors: katayama k, katayama s. Hepatogastroenterology. 2002 May-Jun;49(45):774-7. Hepatogastroenterology. 2002. PMID: 12063988

9

Risk of liver cirrhosis and hepatocellular carcinoma in subjects with hepatitis B and delta virus infection: a study from Kure, Japan.

Tamura I, Kurimura O, Koda T, Ichimura H, Katayama S, Kurimura T, Inaba Y. Tamura I, et al. Among authors: katayama s. J Gastroenterol Hepatol. 1993 Sep-Oct;8(5):433-6. doi: 10.1111/j.1440-1746.1993.tb01543.x. J Gastroenterol Hepatol. 1993. PMID: 8218990

10

[A case of hepatocellular carcinoma treated by intrahepatic arterial administration of anticancer agents: serial determination of the concentration of the chemotherapeutic agents in serum and dialysate during hemodialysis].

Yoshida T, Ohsawa K, Goto T, Chiba S, Nakamura Y, Kondoh K, Sasaki S, Sekine K, Katayama S, Moriai O, et al. Yoshida T, et al. Among authors: katayama s. Gan To Kagaku Ryoho. 1990 Nov;17(11):2257-60. Gan To Kagaku Ryoho. 1990. PMID: 2173495 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,358 results

Search Page